BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2812639)

  • 1. Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomas.
    Sinclair AJ; Bomanji J; Harris P; Ross G; Besser GM; Britton KE
    Nucl Med Commun; 1989 Aug; 10(8):567-76. PubMed ID: 2812639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
    Shapiro B
    Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
    Bomanji J; Levison DA; Flatman WD; Horne T; Bouloux PM; Ross G; Britton KE; Besser GM
    J Nucl Med; 1987 Jun; 28(6):973-8. PubMed ID: 3585505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
    Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
    Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma.
    Nguyen HH; Proye CA; Carnaille B; Combemale F; Pattou FN; Huglo D
    Aust N Z J Surg; 1999 May; 69(5):350-3. PubMed ID: 10353549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
    Suga K; Ogasawara N; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
    Eur J Nucl Med; 2000 May; 27(5):574-82. PubMed ID: 10853814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
    Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
    Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
    van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
    J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma.
    Kayano D; Taki J; Fukuoka M; Wakabayashi H; Inaki A; Nakamura A; Kinuya S
    Nucl Med Commun; 2011 Oct; 32(10):941-6. PubMed ID: 21876405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid clearance of iodine-131 MIBG from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma.
    Nakajo M; Shimabukuro K; Miyaji N; Shimada J; Shirono K; Sakata H; Yoshimura H; Yonekura R; Shinohara S
    J Nucl Med; 1985 Apr; 26(4):357-65. PubMed ID: 3981255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
    Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
    Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
    J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the function of normal adrenomedullary tissue in patients with phaeochromocytomas and other paragangliomas.
    Bomanji J; Bouloux PM; Levison DA; Flatman WD; Horne T; Britton KE; Ross G; Besser GM
    Eur J Nucl Med; 1987; 13(2):86-9. PubMed ID: 3609058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
    Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
    J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.